SASKATCHEWAN REGISTERED NURSES ASSOCIATION

Similar documents
GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus.

WHAT IS GASTROESOPHAGEAL REFLUX DISEASE (GERD)?

Heartburn Overview. Causes & Risk Factors

Reflux of gastric contents, particularly acid, into the esophagus

Gastroesophageal Reflux Disease (GERD)



Gastroesophageal Reflux Disease (GERD)

Chalazia can recur, and those that do should be evaluated for malignancy.

Gastroesophageal reflux (GER) Gastroesophageal reflux (GER), the passage of gastric contents into the esophagus, is a normal physiologic process that

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease

Definition: gas tro e soph a ge al re f lux dis ease (GERD) from Stedman's Medical Dictionary for the Health Professions and Nursing

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

TBURN TBURN BURN ARTBURN EARTBURN EART HEARTBURN: HOW TO GET IT OFF YOUR CHEST

Laryngopharyngeal Reflux

GERD: A linical Clinical Clinical Update Objectives

Peptic ulcer disease Disorders of the esophagus

James Paget University Hospitals. NHS Foundation Trust. Hiatus hernia. Patient Information

Heartburn. Understanding and Treating. Heal n Cure For appointments call

Optimizing the Upper GI: Mind, Mouth, and Stomach What Can Go Wrong With Dr. Ritamarie Loscalzo

Gastroesophageal Reflux Disease, Paraesophageal Hernias &

APHTHOUS STOMATITIS ADULT & PEDIATRIC

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4

GERD. More Than Just Heartburn. written by Harvard Medical School

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

You May Be at Risk. You are currently taking a proton pump inhibitor (PPI):

Silent reflux (also known as LPR or EOR)

Putting Chronic Heartburn On Ice

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

PRESCRIBING SUPPORT TEAM AUDIT: PROTON PUMP INHIBITOR PRESCRIBING REVIEW

QUICK QUERIES. Topical Questions, Sound Answers

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Gastro Esophageal Reflux Disease

Gastro-oesophageal reflux disease and peptic ulcer disease. By: Dr. Singanamala Suman Assistant Professor Department of Pharm.D

Unmet Needs in the Management of Gastroesophageal Reflux Disease

Gastro esophageal reflux disease DR. AMMAR I. ABDUL-LATIF

Barrett s Oesophagus Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015

GERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018

GASTROESOPHAGEAL REFLUX

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

Policy Evaluation: Proton Pump Inhibitors (PPIs)

Corporate Medical Policy

HEARTBURN & REFLUX FUNDING RESEARCH INTO DISEASES OF THE GUT, LIVER & PANCREAS

A Trip Through the GI Tract: Common GI Diseases and Complaints. Jennifer Curtis, MD

Page 1. Objectives. The Role of the Pharmacist as Gatekeeper to the Appropriate Use of OTC PPI Therapy in Frequent Heartburn

You May Be at Risk. You are currently taking a proton-pump inhibitor (PPI): Dexlansoprazole (Dexilant ) Pantoprazole (Pantoloc, Panto IV )

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)

Copy right protected Page 1

Maximizing Outcome of Extraesophageal Reflux Disease. (GERD) is often accompanied

GI Pharmacology. Dr. Alia Shatanawi 5/4/2018

Laparoscopic Anti-Reflux (GERD) Surgery Patient Information from SAGES

Management of Dyspepsia

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014

ACID REFLUX & GERD: The Unsettling Reality in Canada

Nexium 24HR Pharmacy Training

GASTRO-OESOPHAGEAL REFLUX DR RONALDA DELACY

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults

PATIENT INFORMATION FROM YOUR SURGEON & SAGES Laparoscopic Anti-Reflux (GERD) Surgery

Burning Issues in Gastroesophageal Reflux Disease (GERD)

Silent Reflux. Adult Speech & Language Therapy Macclesfield District General Hospital

and Gastro-oesophageal Reflux What symptoms might I expect?

Understanding GERD. & Stretta Therapy. GERD (gĕrd): Gastroesophageal Reflux Disease

Drug Class Monograph

Management of dyspepsia in adults in primary care

Hiatus Hernia. Endoscopy Department. Patient information leaflet

Relieving Frequent Heartburn Day Through Night

235 60th Street, West New York, NJ T: (201) F: (201) Main Street, Hackensack, NJ T: (201)

T.Broda, Solution-s 1

HEARTBURN (GASTROESOPHAGEAL REFLUX)

Module 2 Heartburn Glossary

There are many different symptoms of GER. Your child may only have a few of these symptoms. The most common symptoms include:

OTC PPI Therapy in Frequent Heartburn

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group)

SASKATCHEWAN REGISTERED NURSES ASSOCIATION. RNs WITH ADDITIONAL AUTHORIZED PRACTICE CLINICAL DECISION TOOL AUGUST 2017

Gastro-Oesophageal Reflux Disease Information Sheet

National Digestive Diseases Information Clearinghouse

Outline. Outline. Definition. Asthma, GERD and Laryngeal Pharyngeal Reflux (LPR) Definitions

Dysphagia. Conflicts of Interest

Proton Pump Inhibitors Drug Class Prior Authorization Protocol

THE CONNECTIVE TISSUE AND EPITHELIUM

Concise guide to management of reflux disease in primary care

A. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.

GUIDELINES FOR CLINICIANS. Gastro-Oesophageal Reflux Disease in Adults. Reflux Disease. 4th Edition Digestive Health Foundation

Gastroesophageal Reflux (GER) and Gastroesophageal Reflux Disease (GERD) in Adults

For this session on the esophagus, I have selected three conditions that are somewhat related, namely gastro esophageal reflux disease, which from

UPPER GI DISEASES 11/15/2014. Lesson Objectives. GI Tract Review. NUTR 2050 Nutrition for Nursing Professionals. Mrs. Deborah A. Hutcheon, MS, RD, LD

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

In the Name of God. Refractory GERD

PREPARING FOR REFLUX TESTING. Digitrapper Reflux Testing System

DYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people

Esophageal Disorders. Learning Objectives. Introduction. Gastroesophageal Reflux Disease. Reza Shaker, MD, and Benson T.

Refractory GERD : case presentation and discussion

Inflammation of the Esophagus (Esophagitis) Basics

LINX. A new, FDA approved treatment for GERD

Gastroesophageal Reflux Disease (GERD)

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

Transcription:

DEFINITION Reflux of gastric contents into the esophagus, which results in esophageal irritation or inflammation. IMMEDIATE CONSULTATION REQUIRED IN THE FOLLOWING SITUATIONS Dysphagia (solid food, progressive) Odynophagia (painful swallowing) Bleeding/anemia Weight loss Persistent vomiting Gastroesophageal Reflux Disease (GERD) symptoms that could be cardiac in origin Respiratory symptoms secondary to reflux No response to 8 weeks of medical therapy CAUSES Reflux of acidic stomach contents in the esophagus due to laxity of the lower esophageal sphincter. PREDISPOSING AND RISK FACTORS Obesity Pregnancy Estrogen therapy Medications (nitrates, anticholinergics, calcium channel blockers) Tobacco use Alcohol use Genetic factors Defective esophageal clearance Hypersecretion of gastric acid High-fat diet Hiatus hernia Diabetes Delayed gastric emptying High adrenergic drive (e.g., stress, anxiety) 1 P age

HISTORY Heartburn, most often after eating Retrosternal burning sensation radiating upward (may radiate as far up as the throat) Acidic stomach contents may be regurgitated Disturbed sleep from symptoms Dry cough at night Associated symptoms may include: o Cough, sore throat, hoarseness, wheezing o Difficulty swallowing (from erosive esophagitis or narrowing of esophagus) o Painful swallowing (from esophageal ulcer) o Nausea o Hypersalivation (water brash) o Night cough, night awakenings due to pain o Globus sensation (feeling of something stuck in throat) Aggravating factors may include: o Large meals o Lying down and bending over o Certain foods (common irritants include caffeine, chocolate, alcohol, peppermint, fatty foods) o Tight-fitting clothes o Increased perception of symptoms with stress Alleviating factors may include: o Relief with antacids, gum chewing o Sitting up, lifting head of bed o Avoidance of certain foods or beverages to limit symptoms PHYSICAL FINDINGS Assess weight Mild epigastric tenderness may be present DIFFERENTIAL DIAGNOSIS Peptic ulcer disease Esophageal motility disorder 2 P age

Gastrointestinal (GI) bleeding Esophageal tumour Esophagitis (pill esophagitis, infectious esophagitis, eosinophilic esophagitis) Anginal/cardiac pain Medication-induced epigastric pain Biliary pain Pancreatitis Gastritis COMPLICATIONS Barrett esophagus (pre-malignant mucosal changes due to chronic GERD, most common > 50 years of age) Esophagitis/esophageal ulcer Esophageal stricture Nocturnal aspiration (choking, cough, asthma, recurrent pneumonitis) Posterior laryngitis, chronic hoarseness Dental erosions Chronic sinusitis Pharyngitis Subglottic stenosis Laryngeal/esophageal cancer INVESTIGATIONS AND DIAGNOSTIC TESTS Diagnosis is usually made on clinical exam and further investigations are usually not required unless the client fails to respond to treatment within 8 weeks. Referral for further investigations should be made. Clients with alarm features of GERD, as listed in the Immediate Consultation Required in the Following Situations section, require prompt referral and investigation (endoscopy is the preferred diagnostic test). MAKING THE DIAGNOSIS Diagnosis of GERD can usually be established on the basis of a careful history and physical examination. 3 P age

Clients who complain about heartburn and/or regurgitation at least twice weekly are considered to have GERD, unless they have additional symptoms, or a trial of therapy for GERD has failed. GERD is not caused by Helicobacter pylori infection and eradication of H. pylori is not known to affect the disease or its management. MANAGEMENT AND INTERVENTIONS Goals of Treatment Relieve symptoms, especially heartburn Promote healing of the esophagus Prevent complications such as stricture, bleeding, Barrett esophagus Prevent recurrence Appropriate Consultation Symptoms/presentations in the Immediate Consultation Required in the Following Situations section. Any symptoms of dysphagia need urgent consultation and investigation. Clients who have not responded to 8 weeks of treatment should be referred for further investigations. Consult with a physician/rn(np) if client is taking medications that impair esophageal motility and lower esophageal sphincter tone (e.g., calcium channel blockers, beta-blockers, tricyclic antidepressants, anticholinergics, theophyllines), to determine if any adjustments are required. Non-Pharmacological Interventions Weight loss Reduction of alcohol, tobacco and caffeine intake Avoid lying down within 2 hours of eating Elevation of the head of the bed Avoidance of foods that trigger symptoms: o Spices o Peppermint o Chocolate o Citrus juices 4 P age

o Caffeine Pharmacological Interventions Initial Management o If symptoms occur less than 3 times per week Lifestyle modifications Antacids as needed to control symptoms Aluminum hydroxide/magnesium hydroxide 30 ml orally after meals and before bed Histamine H2-receptor antagonists Ranitidine (Zantac) 150 mg orally bid If client fails to respond to initial management strategies after 4 weeks add: o Proton pump inhibitor (PPI) once daily for 4-8 weeks Pantoprazole (Pantoloc) 40 mg orally once daily Pantoprazole magnesium (Tecta) 40 mg orally once daily Omeprazole (Losec) 20 mg orally once daily RABEprazole (Pariet) 20 mg orally once daily Lansoprazole (Prevacid) 30 mg orally once daily If symptoms are not resolved by treatment or if symptoms recur, consultation with a physician/rn(np) is required. Client and Caregiver Education Elevate the head of the bed 15 cm (6 in) using wooden blocks Encourage weight loss (if weight > 20% of ideal body weight for age and sex) Counsel client/caregiver about appropriate use of medications (dose, frequency, compliance, etc.). Recommend: o Dietary modifications (decrease or eliminate coffee, tea, chocolate, nicotine, alcohol and fatty foods) 5 P age

o Smoking cessation (decreases salivation) o Small, frequent meals to prevent over-distension of the stomach o Avoidance of eating large meals/snacks 2-3 hours before bedtime o Postural modifications (daytime and nocturnal) to prevent acid from entering the esophagus (elevate head of bed 15 cm [6 in] using blocks) o Avoid bending at the waist (especially after meals), as well as lying down immediately, and within 2 hours after a meal o Avoidance of tight-fitting clothing Monitoring and Follow-Up Monitor every 4 weeks Continue therapy to which client is responding for 8-12 weeks Reassess for symptom relapse in 4-8 weeks when therapy complete. If symptoms recur, resume previous therapeutic regimen and refer client to a physician/rn(np). Referral Presentation consistent with those in the Immediate Consultation Required in the Following Situations section. Client who fails to respond to pharmacological treatment in 8 weeks. Client whose symptoms return after completing 8 week treatment regime. DOCUMENTATION As per employer policy REFERENCES British Columbia Ministry of Health. (2010). Gastroesophageal reflux disease: Clinical approach in adults. Retrieved from http://www.bcguidelines.ca/guideline_gerd.html Health Canada. (2011). First Nations and Inuit health: Clinical practice guidelines for nurses in primary care. Retrieved from http://www.hc-sc.gc.ca Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology, 108, 308 328. doi: 10.1038/ajg.2012.444 6 P age

Rx Files Academic Detailing Program. (2014). Rx Files: Drug comparison charts. Saskatoon, SK: Saskatoon Health Region. Vakil, N. (2013). The initial diagnosis of GERD. Best Practice & Research in Clinical Gastroenterology, 27(3), 365-371. doi: 10.1016/j.bpg.2013.06.007 Vela, M. F. (2014). Diagnostic work-up of GERD. Gastrointestinal Endoscopy Clinics of North America, 24(4), 655-666. doi: 10.1016/j.giec.2014.07.002 NOTICE OF INTENDED USE OF THIS This SRNA Clinical Decision Tool (CDT) exists solely for use in Saskatchewan by an RN with additional authorized practice as granted by the SRNA. The CDT is current as of the date of its publication and updated every three years or as needed. A member must notify the SRNA if there has been a change in best practice regarding the CDT. This CDT does not relieve the RN with additional practice qualifications from exercising sound professional RN judgment and responsibility to deliver safe, competent, ethical and culturally appropriate RN services. The RN must consult a physician/rn(np) when clients needs necessitate deviation from the CDT. While the SRNA has made every effort to ensure the CDT provides accurate and expert information and guidance, it is impossible to predict the circumstances in which it may be used. Accordingly, to the extent permitted by law, the SRNA shall not be held liable to any person or entity with respect to any loss or damage caused by what is contained or left out of this CDT. SRNA This CDT is to be reproduced only with the authorization of the SRNA. 7 P age